Pathogen spectrum and microbiome in lower respiratory tract of patients with different pulmonary diseases based on metagenomic next-generation sequencing

Rujun Hong,Sheng Lin,Siting Zhang,Yaxing Yi,Lanfeng Li,Haitao Yang,Zhenshan Du,Xuefang Cao,Wenjie Wu,Ruotong Ren,Xiujuan Yao,Baosong Xie
DOI: https://doi.org/10.3389/fcimb.2024.1320831
IF: 6.073
2024-10-31
Frontiers in Cellular and Infection Microbiology
Abstract:Introduction: The homeostasis of the microbiome in lower respiratory tract is crucial in sustaining normal physiological functions of the lung. Different pulmonary diseases display varying degrees of microbiome imbalance; however, the specific variability and clinical significance of their microbiomes remain largely unexplored. Methods: In this study, we delineated the pathogen spectrum and commensal microorganisms in the lower respiratory tract of various pulmonary diseases using metagenomic sequencing. We analyzed the disparities and commonalities of the microbial features and examined their correlation with disease characteristics. Results: We observed distinct pathogen profiles and a diversity in lower airway microbiome in patients diagnosed with cancer, interstitial lung disease, bronchiectasis, common pneumonia, Nontuberculous mycobacteria (NTM) pneumonia, and severe pneumonia. Discussion: This study illustrates the utility of Metagenomic Next-generation Sequencing (mNGS) in identifying pathogens and analyzing the lower respiratory microbiome, which is important for understanding the microbiological aspect of pulmonary diseases and essential for their early and precise diagnosis.
immunology,microbiology
What problem does this paper attempt to address?